相关实验视频
Updated: Jul 15, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
脉冲单克隆抗体治疗和自身免疫性甲状腺疾病在多发性硬化症
1University of Cambridge Neurology Unit, University of Cambridge, UK. alasdair_coles@hotmail.com
短期Campath-1H治疗通过改变T细胞反应,抑制了多发性硬化症 (MS) 疾病活动18个月. 然而,它也导致了一些患者的甲状腺自身免疫.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 临床医学 临床医学
背景情况:
- 多发性硬化症 (MS) 是由T细胞驱动的中枢神经系统的炎症性脱髓化疾病.
- 目前的治疗方法旨在通过短期干预来长期控制炎症.
研究的目的:
- 评估短期单克隆抗体治疗抑制MS炎症的长期疗效.
- 评估Campath-1H在MS患者的临床,免疫和血液学影响.
主要方法:
- 对27名多发性硬化患者进行了Campath-1H (抗CD52单克隆抗体) 的5天脉冲治疗.
- 耗尽了大约95%的循环淋巴细胞.
- 18个月监测临床和血液学参数,以及体外外周围血液单核细胞反应.
主要成果:
- 在至少18个月的时间里,MS疾病活动的放射性和临床标志物显著减少.
- 三分之一的患者产生了抗甲状腺素受体抗体,导致自身免疫性甲状腺功能障碍.
- 重建的淋巴细胞在体外显示减少了扩散和干扰素-玛分泌.
结论:
- 坎帕特-1H治疗将免疫反应从Th1表型转移,有效抑制MS活动.
- 治疗允许抗体介导的甲状腺自身免疫的发展.
- 坎帕特-1H为MS提供了潜在的治疗策略,但存在二次自身免疫性疾病的风险.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
08:43Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cardiomyopathy IV: Restrictive Cardiomyopathy